DOCSLIB.ORG

Endometriosis and Women's Reproductive Life

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Endometriosis and Women's Reproductive Life 1ST CONGRESS OF THE SOCIETY OF ENDOMETRIOSIS AND UTERINE DISORDERS Endometriosis and women’s reproductive life 2015 MAY 7-8-9 Location Congress President Paris, France Pr Charles Chapron, Paris, France Marriott Rive Gauche Table of contents 4 WELCOME NOTE 5 BOARDS / FACULTIES AND INTERNATIONAL COMMITTEE 6 PROGRAM 24 SOCIAL PROGRAM 26 PARIS, A FABULOUS HERITAGE 28 PARTNERS Join a growing list of surgeons experiencing the unique functions of the PlasmaJet® Surgery System. Use Kinetic Dissection™ to help you visualize and dissect tissue planes and Microlayer Vaporization™ to enable you to perform more complete disease removal. Illustrated example of PlasmaJet being used to vaporize endometrial lesions in a controlled fashion. © Copyright 2015 Plasma Surgical. All rights reserved. Respect for Tissue. 3 Welcome to Paris Board Dear friends and colleagues, CONGRESS PRESIDENT : ORGANIZING COMMITTEE Charles Chapron, France Bruno Borghese, On behalf of the scientific board and the organizing committee, I am honored to wel- Vanessa Gayet come you in Paris for the first congress of the “Society of Endometriosis and Uterine Arnaud Le Tohic, Disorders” (SEUD). Louis Marcellin, Pierre Panel, The aim of SEUD is to offer an international scientific platform for giving the possibility Pietro Santulli, to have a comprehensive approach of womens’ health in the field of benign gynecolo- Dominique de Ziegler gical diseases related to uterine dysfunctions. The objective of the SEUD is to focus the attention on a group of benign gynecological diseases which affect womens’ health (en- dometriosis, adenomyosis, uterine fibroids, polyps, heavy menstrual bleeeding, uterine malformations and others). Faculties and The congress has been designed to provide an innovative and comprehensive overview of the latest research developments in endometriosis, in uterine disorders and in wo- international committee men’s reproductive life fields. A F P Many distinguished scientists from all over the world take part to this congress. I would Mauricio Abrao, Brazil Jacques Faidherbe, France Pierre Panel, France like to sincerely thank them for their investment. Moamar Al-Jefout, Jordan Arnaud Fauconnier, France Antonio Pellicer, Spain B Hervé Fernandez, France Felice Petraglia, Italy The steering Committee hopes this meeting will provide an exceptional opportunity for Frédéric Batteux, France Yoke Fai Fong, Singapore Carlos Petta, Brazil you to share your expertise in order to develop and Jean-Louis Benifla, France Hervé Foulot, France George Pistofidis, Greece facilitate ongoing collaborations and studies. Stefano Bettocchi, Italy G Alexander Popov, Russia The congress will be articulated around plenary ses- Bruno Borghese, France Juan Garcia-Velasco, Spain Jean-Luc Pouly, France sions, conferences, debates, KOL positions, sympo- Antoine Bourret, France Vanessa Gayet, France Gérard Priou, France sia, live surgery… Moreover free communications, Ivo Brosens, Belgium François Golfier, France R posters and videos assure this meeting will know a Serdar E. Bulun, USA Sun-Wei Guo, China Fernando Reis, Brazil resounding success. C H Horace Roman, France I am honored to Michel Canis, France Tasuku Harada, Japan Bo R. Rueda, USA We hope that you will enjoy the congress and that Francisco Carmona, Spain Oskari Heikinheimo, Finland S your interaction with your colleagues from different welcome you all in Charles Chapron, France Thomas d’Hooghe, Belgium Pietro Santulli, France countries will stimulate a creative exchange of ideas Jung-Hye Choi, Korea K Gamal Serour, Egypt and will be personally rewarding. We also hope and Pasquapina Ciarmela, Italy Joerg Keckstein, Austria Edgardo Somigliana, Italy trust that you will enjoy your visit to the very beautiful Paris for the first SEUD and exciting city of Paris. Justin Clark, UK Rosanne M. Kho, USA Isabelle Streuli, Switzerland congress. Pierre Collinet, France L T Yours sincerely Hilary Critchley, UK Philippe Y. Laberge, Canada Hugh S. Taylor, USA C. Chapron D Marie Christine Lafay-Pillet, France Jim Tsaltas, Australia Philippe Descamps, France Arnaud Le Tohic, France V Professor Charles Chapron, Paul Devroey, Belgium M Daniel Vaiman, France 1st SEUD Congress President Pierre-Hervé Dorangeon, France Maguette Mbaye, Senegal Sebastiaan Veersema, The Netherlands Paris, France Bertrand Dousset, France Louis Marcellin, France Valérie Vernaeve, Spain E Anne-Elodie Millischer, France Z Jean-Philippe Estrade, France Michael Mueller, Switzerland Dominique de Ziegler, France N Errico Zupi, Italy Julien Niro, France 4 5 PROGRAM 7 Program ataglance THURSDAY 7TH OF MAY FRIDAY 8TH OF MAYSATURDAY 9TH OF MAY 7.30 > 8.00 > WELCOME DESK OPENING PELVIC 8.30 > PAIN COURSE 9.00 > TIONS TIONS UTERINE SESSION FIBROIDS SCGP / SEUD 9.30 > EN FRANCE ET AILLEURS - ENDOMETRIOSIS IN FRANCE AND FREE COMMUNICA FREE COMMUNICA VIDEO SESSION AND INFERTILITY 10.00 > ELSEWHERE LIVE SURGERY KEYNOTE LECTURE SESSION EPIGENETICS AND ENDOMETRIOSIS 10.30 > COFFEE BREAK COFFEE BREAK Current and future AND EXHIBITION VISIT AND EXHIBITION VISIT perspectives: Visanne® 11.00 > and new research targets in endometriosis CANADIAN SESSION ENDOMETRIOSIS : 11.30 > TIONS TIONS SYMPOSIUM ON FUTURE AND ADENOMYOSIS FIBROIDS ADVANCES AND IN RESEARCH 12.00 > ENDOMETRIOSIS FREE COMMUNICA FREE COMMUNICA VIDEO SESSION 12.30 > KEYNOTE LECTURE FUTURE DRUGS FOR IPSEN SYMPOSIUM ENDOMETRIOSIS COCKTAIL LUNCH 13.00 > New insights to AND EXIBITION VISIT Mirena® in the NORDIC PHARMA management of SYMPOSIUM 13.30 > heavy menstrual bleeding COCKTAIL LUNCH AND EXHIBITION VISIT MEDICAL MANAGEMENT OF COCKTAIL LUNCH 14.00 > UTERINE FIBROIDS AND EXHIBITION VISIT WITH ULIPRISTAL ACETATE KOL POSITIONS 14.30 > OPENING CEREMONY TIONS TIONS TIONS TIONS SEUD GENERAL ASSEMBLY 15.00 > ENDOMETRIOSIS AND FREE COMMUNICA FREE COMMUNICA FREE COMMUNICA FREE COMMUNICA 15.30 > REPRODUCTIVE UNDERSTANDING LIFE DEEP KOL ENDOMETRIOSIS FROM CLOSING AND AWARDS CEREMONY POSITIONS TIONS TIONS TIONS TIONS DIAGNOSIS TO INNOVATIVE 16.00 > TREATMENT COFFEE BREA 16.30 > AND EXHIBITION VISIT LIVE SCAN FREE COMMUNICA FREE COMMUNICA FREE COMMUNICA FREE COMMUNICA 17.00 > COFFEE BREAK AND EXHIBITION VISIT PATIENTS SESSION ABNORMAL UTERINE 17.30 > BLEEDING DEBATE : IMAGING FOR ENDOMETRIOSIS SESSION SCGP / SEUD AND UTERINE RUSSIAN SESSION DISORDERS EN FRANCE ET 18.00 > AILLEURS - IN DEBATE : SURGERY FRANCE AND KEYNOTE LECTURE FOR DEEP ELSEWHERE DNA, STEMS CELLS, STEROIDS, ENDOMETRIOSIS 18.30 > ENDOMETRIOSIS AND UTERINE FIBROIDS : DANGEROUS LIAISONS KEYNOTE LECTURE ABNORMAL UTERINE BLEEDING – AN UNMET NEED – 19.00 > WELCOME RECEPTION : CURRENT CLASSIFICATION, CAUSES AND CARE POSTERS PRESENTATIONS&S & CHEESE AND WINE 19.30 > 20.00 > 20.30 > SOCIAL EVENING 21.00 > SCÈNE B SCÈNE C FORUM A FORUM B FORUM C FORUM G FORUM H FORUM I FORUM J 8 Program 14.30 Scène B & C Room - Plenary session Opening ceremony Chair : Charles Chapron (France) - Co Chair : Felice Petraglia (Italy) 14.45 Scène B & C Room - Plenary session THURSDAY 7TH OF MAY 16.15 Endometriosis and reproductive life Chair : Yoke Fai Fong (Singapore) - Co Chair : Jim Tsaltas (Australia) 7.45 Welcome desk opening , Fetal roots of endometriosis, Ivo Brosens (Belgium) , Is adolescence a crucial period for endometriosis patients ? Thomas d’Hooghe (Belgium) 08.30 Scène C Room , Perimenopausal endometriosis, Fernando Reis (Brazil) 12.00 Live surgery session from Versailles Hospital and Rouen Hospital , Endometriosis and quality of life, Pistofidis George (Greece) Chair : Bruno Borghese (France) - Co Chairs : Alexander Popov (Russia)), Emmanuel Bailly (France) Discussion Chair : Moamar Al Jefout (Jordan) - Co Chairs : Hervé Foulot (France), Emmanuel Bailly (France) , 16.15 Coffee break and exhibition visit 09.45 Scène B Room 11.45 Current and future perspectives : Visanne® and new research targets 16.45 Scène B & C Room - Plenary session in endometriosis 18.15 Abnormal uterine bleeding , Welcome and introduction, Carlos Petta (Brazil) Chair : Carlos Petta (Brazil) - Co Chair : Maguette Mbaye (Senegal) , Why approach endometriosis as an inflammatory disease ? Pietro Santulli (France) , AUB management : how do systematic reviews and meta-analysis help ? Justin Clark (UK) The mechanism(s) of LNG-IUS action in the heavy menstrual bleeding treatment, , Tailoring endometriosis treatment: medical and surgical options, Renato Seracchioli (Italy) , Oskari Heikinheimo (Finland) ® Endometrial ablation : past, present and future, , Evidence-based management of endometriosis with Visanne , Andreas D. Ebert (Germany) , Philippe Y. Laberge (Canada) AUB and pelvic pain : specific management, ) , How can we best manage our patients for the long term ? Sony S. Singh (Canada) , Errico Zupi (Italy Discussion , Bayer’s future medical treatment options, Thomas M. Zollner (Germany) , , Q&A, summary, own experience and close, Carlos Petta (Brazil) 18.15 Scène B & C Room - Keynote lecture 18.45 12.15 Scène B Room DNA, stems cells, steroids, endometriosis and uterine fibroids : 13.45 New insights to Mirena® in the management of heavy menstrual bleeding dangerous liaisons Chair : Hervé Fernandez (France) Serdar E. Bulun (USA) , The global burden of HMB, Joaquin Calaf (Spain) Chair : Felice Petraglia (Italy) How does Mirena® compare to other treatments for HMB ? , Marc-Yvon Arsenault (Canada) 18.45 Welcome reception : Posters presentations & cheese and wine , Mirena® in the management of HMB in special patient groups, Oskari Heikinheimo (Finland) Original 12.15 Scène C Room 13.15 Endometriosis: taking into account the
Load more

Recommended publications
  • Transplantation and Immunology 1
    Transplantation and Immunology 1 Transplantation and Immunology บรรยายโดย อ.นพ.สมชัย ลิ้มศรีจ าเริญ เรียบเรียง นพ.กิตติ์รวี จิรธานีเรืองกิจ อาจารย์ที่ปรึกษา อ.นพ.ราวิน วงษ์สถาปนาเลิศ Outline 1. Immunology 2. Immunosuppression: drug use in transplantation 3. Clinical transplant: liver pancreas intestine and kidney transplant ในอเมริกา ท า Transplant เยอะมาก และ resident ศัลยกรรมทุกคนต้องผ่าน rotation transplant ดังนั้น ในอนาคต บ้านเรา จะท ากันมากขึ้น และอาจจะบรรจุ เป็น requirement ให้ resident ต้องผ่าน • Immunology ประวัติศาสตร์ เริ่มจาก Jensen reported in 1902 - มีการทดลอง ศึกษาเกี่ยวกับ tumor และ immunology ของ tumor พบว่า สามารถน าเอา tumor จากหนูไป transplant ให้ตัวอื่นได้ ( ท าใน 19 successive generation) - พบว่าหนูบางส่วนจะ reject tumor ไม่ให้เติบโต (50% of mice) - โดยจะ reject ทุกครั้ง ที่น า tumor มา transplant ใหม่ (มี resistant to subsequent challenge) และ หากน า เอา normal tissue ใส่ไปก่อน และเอา tumor มา transplant ก็จะ reject ได้เร็วขึ้น - เกิด Theory อธิบายเหตุการณ์นี้ คือ Athrepsia theory (เกี่ยวกับ nutrition) เพราะ เวลาใส่ tumor เข้าไปแรกๆ จะยังเจริญได้ช่วงหนึ่งจากนั้น จึงตายไป เชื่อว่าเกิดจากการขาด สารอาหาร หลังจาก tumor ใช้สารอาหารหมด มันก็จะตายไป นับเป็นจุดเริ่มต้นที่ใช้ tumor ในการศึกษาหลักการเรื่อง Transplantation Medawar reported in 1943 (Nobel prize) - เมื่อมี rejection เกิดขึ้น หากเราใช้ graft ครั้งที่ 2 จาก donor เดิม จะเกิดการ reject เร็วขึ้น ซึ่งคิดว่าเกิดจาก Actively acquired immune reaction จากนั้นมีการศึกษาอีกหลายอย่างเพื่อศึกษา transplant immunology Owen reported in 1947 - ถ้าน าสัตว์เช่น ลูกวัว ที่เป็น dizygotic
    [Show full text]
  • Areas of Future Research in Fibroid Therapy
    9/18/18 Cumulative Incidence of Fibroids over Reproductive Lifespan RFTS Areas of Future Research Blacks Blacks UFS Whites in Fibroid Therapy CARDIA Age 33-46 William H. Catherino, MD, PhD Whites Professor and Chair, Research Division Seveso Italy Uniformed Services University Blacks Whites Associate Program Director Sweden/Whites (Age 33-40) Division of REI, PRAE, NICHD, NIH The views expressed in this article are those of the author(s) and do not reflect the official policy or position of the Department of the Army, Department of Defense, or the US Government. Laughlin Seminars Reprod Med 2010;28: 214 Fibroids Increase Miscarriage Rate Obstetric Complications of Fibroids Complication Fibroid No Fibroid OR Abnormal labor 49.6% 22.6% 2.2 Cesarean Section 46.2% 23.5% 2.0 Preterm delivery 13.8% 10.7% 1.5 BreecH position 9.3% 4.0% 1.6 pp Hemorrhage 8.3% 2.9% 2.2 PROM 4.2% 2.5% 1.5 Placenta previa 1.7% 0.7% 2.0 Abruption 1.4% 0.7% 2.3 Guben Reprod Biol Odds of miscarriage decreased with no myoma comparedEndocrinol to myoma 2013;11:102 Biderman-Madar ArcH Gynecol Obstet 2005;272:218 Ciavattini J Matern Fetal Neonatal Med 2015;28:484-8 Not Impacting the Cavity Coronado Obstet Gynecol 2000;95:764 Kramer Am J Obstet Gynecol 2013;209:449.e1-7 Navid Ayub Med Coll Abbottabad 2012;24:90 Sheiner J Reprod Med 2004;49:182 OR = 0.737 [0.647, 0.840] Stout Obstet Gynecol 2010;116:1056 Qidwai Obstet Gynecol 2006;107:376 1 9/18/18 Best Studied Therapies Hysterectomy Option over Time Surgical Radiologic Medical >100 years of study Hysterectomy Open myomectomy GnRH agonists 25-34 years of study Endometrial Ablation GnRH agonists 20-24 years of study Laparoscopic myomectomy Uterine artery embolization Retinoic acid 10-19 years of study Uterine artery obstruction SPRMs: Mifepristone, ulipristal Robotic myomectomy GnRH antagonists 5-9 years of study Cryomyolysis MRI-guided high frequency ultrasound SPRMs: Asoprisnil, Telapristone, Laparoscopic ablation Vilaprisan SERMs: Tamoxifen, Raloxifene, Letrozole, Genistein Pitter MC, Simmonds C, Seshadri-Kreaden U, Hubert HB.
    [Show full text]
  • Durham E-Theses
    Durham E-Theses Elemental Fluorine for the Greener Synthesis of Life-Science Building Blocks HARSANYI, ANTAL How to cite: HARSANYI, ANTAL (2016) Elemental Fluorine for the Greener Synthesis of Life-Science Building Blocks, Durham theses, Durham University. Available at Durham E-Theses Online: http://etheses.dur.ac.uk/11705/ Use policy The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for personal research or study, educational, or not-for-prot purposes provided that: • a full bibliographic reference is made to the original source • a link is made to the metadata record in Durham E-Theses • the full-text is not changed in any way The full-text must not be sold in any format or medium without the formal permission of the copyright holders. Please consult the full Durham E-Theses policy for further details. Academic Support Oce, Durham University, University Oce, Old Elvet, Durham DH1 3HP e-mail: [email protected] Tel: +44 0191 334 6107 http://etheses.dur.ac.uk 2 Durham University A thesis entitled Elemental Fluorine for the Greener Synthesis of Life-Science Building Blocks by Antal Harsanyi (College of St. Hild and St. Bede) A candidate for the degree of Doctor of Philosophy Department of Chemistry, Durham University 2016 Antal Harsanyi: Elemental fluorine for the greener synthesis of life-science building blocks Abstract Fluorinated organic compounds are increasingly important in many areas of our modern lives, especially in pharmaceutical and agrochemical applications where the incorporation of this element can have a major influence on biochemical properties.
    [Show full text]
  • Victor Hugo's Paris J-Term Course in Paris, France, 2019
    Victor Hugo’s Paris J-Term course in Paris, France, 2019 (ISHU 3720) BIS Program, School of Continuing and Professional Studies December 28, 2018-January 10, 2019 Syllabus DRAFT NB: Details may change because of specialists’ availability, site openings, weather or text availability. Program Director & Instructor: Marva Barnett Professor Emeritus (formerly professor at the UVA Center for Teaching Excellence and in the Drama and French Departments) Important Contact Info Marva Barnett’s cell in France: US cell: TBA Assistant’s US cell in France: TBA “To study in Paris is to be born in Paris!” « Étudier à Paris, c’est être né à Paris! » ― Victor Hugo, Les Misérables I, 3, ii “Whoever contemplates the depths of Paris is seized with vertigo. Nothing is more fantastic, nothing is more tragic, nothing is more superb.” « Qui regarde au fond de Paris a le vertige. Rien de plus fantasque, rien de plus tragique, rien de plus superbe. » ― Victor Hugo, Introduction to Paris-Guide, Part III, 1867 “To stray is human; to saunter is Parisian.” « Errer est humain, flâner est parisien. » ― Victor Hugo, Les Misérables III, 4, i Note: To get Hugo’s joke, you need to understand the French pun. “Errer” means both “to err” and “to stray, or get lost” and “errer est humain“ is as familiar as our “to err is human.” Course Description: One might argue, as slate.fr has, that Victor Hugo is Paris. A great Romantic poet and world-renowned novelist and social-justice fighter, Victor Hugo dominated nineteenth-century Paris. Students taking this BIS-affiliated J-Term course, “Victor Hugo’s Paris” will explore the City of Lights from literary, historical, artistic, biographical and cultural perspectives.
    [Show full text]
  • Paris & London Architecture & Urbanism Program Suggested
    Paris & London Architecture & Urbanism Program Suggested Activities in Paris Summer 2018 Use this list of other temporary exhibits, events, and lesser-known museums around Paris to explore other activities on your own based on your areas of interest. …And don’t forget to check out the Facebook page for Boston University Study Abroad– Paris for info about events, exhibits, cinema, and visits going on during your stay in Paris! Picasso: History of the Guernica Celebrating the 80th anniversary of the creation of one of Picasso’s most famous and exceptional paintings, the National Picasso Museum in Paris in partnership with the Queen Sophia National Museum has dedicated an entire exhibit to the history of the Guernica. Painted in 1937, this monumental work of art became an iconic symbol of both anti-fascism and peace. Artists, historians, and intellectuals have been debating its true meaning since its creation. This singular exhibit traces Picasso’s artistic journey through the ‘30s and how the Spanish civil war impacted his work. (Inspirelle.com) When: Through July 29 Tues-Fri 10:30am-6pm Sat-Sun 9:30am-6pm Where: Musée Picasso Paris 5 rue de Thorigny 75003 Paris Metro: Saint Paul (line 1) or Saint-Sébastien-Froissant or Chemin Vert (both line 8) Cost: 11€ with passport and student card (may be free if your visa is longer), free 1st Sun of the month Website: http://www.museepicassoparis.fr/exposition-guernica/ Champs-Elysées Film Festival This annual film festival showcases American and French independent films for a week with premieres, conferences, after parties, and live music.
    [Show full text]
  • Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
    US 20190192440A1 (19 ) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2019 /0192440 A1 LI (43 ) Pub . Date : Jun . 27 , 2019 ( 54 ) ORAL DRUG DOSAGE FORM COMPRISING Publication Classification DRUG IN THE FORM OF NANOPARTICLES (51 ) Int . CI. A61K 9 / 20 (2006 .01 ) ( 71 ) Applicant: Triastek , Inc. , Nanjing ( CN ) A61K 9 /00 ( 2006 . 01) A61K 31/ 192 ( 2006 .01 ) (72 ) Inventor : Xiaoling LI , Dublin , CA (US ) A61K 9 / 24 ( 2006 .01 ) ( 52 ) U . S . CI. ( 21 ) Appl. No. : 16 /289 ,499 CPC . .. .. A61K 9 /2031 (2013 . 01 ) ; A61K 9 /0065 ( 22 ) Filed : Feb . 28 , 2019 (2013 .01 ) ; A61K 9 / 209 ( 2013 .01 ) ; A61K 9 /2027 ( 2013 .01 ) ; A61K 31/ 192 ( 2013. 01 ) ; Related U . S . Application Data A61K 9 /2072 ( 2013 .01 ) (63 ) Continuation of application No. 16 /028 ,305 , filed on Jul. 5 , 2018 , now Pat . No . 10 , 258 ,575 , which is a (57 ) ABSTRACT continuation of application No . 15 / 173 ,596 , filed on The present disclosure provides a stable solid pharmaceuti Jun . 3 , 2016 . cal dosage form for oral administration . The dosage form (60 ) Provisional application No . 62 /313 ,092 , filed on Mar. includes a substrate that forms at least one compartment and 24 , 2016 , provisional application No . 62 / 296 , 087 , a drug content loaded into the compartment. The dosage filed on Feb . 17 , 2016 , provisional application No . form is so designed that the active pharmaceutical ingredient 62 / 170, 645 , filed on Jun . 3 , 2015 . of the drug content is released in a controlled manner. Patent Application Publication Jun . 27 , 2019 Sheet 1 of 20 US 2019 /0192440 A1 FIG .
    [Show full text]
  • EC313-A Tissue Selective SPRM Reduces the Growth and Proliferation of Uterine Fbroids in a Human Uterine Fbroid Tissue Xenograft Model Hareesh B
    www.nature.com/scientificreports OPEN EC313-a tissue selective SPRM reduces the growth and proliferation of uterine fbroids in a human uterine fbroid tissue xenograft model Hareesh B. Nair1*, Bindu Santhamma1, Kalarickal V. Dileep2, Peter Binkley3, Kirk Acosta1, Kam Y. J. Zhang 2, Robert Schenken3 & Klaus Nickisch1 Uterine fbroids (UFs) are associated with irregular or excessive uterine bleeding, pelvic pain or pressure, or infertility. Ovarian steroid hormones support the growth and maintenance of UFs. Ulipristal acetate (UPA) a selective progesterone receptor (PR) modulator (SPRM) reduce the size of UFs, inhibit ovulation and lead to amenorrhea. Recent liver toxicity concerns with UPA, diminished enthusiasm for its use and reinstate the critical need for a safe, efcacious SPRM to treat UFs. In the current study, we evaluated the efcacy of new SPRM, EC313, for the treatment for UFs using a NOD-SCID mouse model. EC313 treatment resulted in a dose-dependent reduction in the fbroid xenograft weight (p < 0.01). Estradiol (E2) induced proliferation was blocked signifcantly in EC313-treated xenograft fbroids (p < 0.0001). Uterine weight was reduced by EC313 treatment compared to UPA treatment. ER and PR were reduced in EC313-treated groups compared to controls (p < 0.001) and UPA treatments (p < 0.01). UF specifc desmin and collagen were markedly reduced with EC313 treatment. The partial PR agonism and no signs of unopposed estrogenicity makes EC313 a candidate for the long-term treatment for UFs. Docking studies have provided a structure based explanation for the SPRM activity of EC313. Te unmet need for medical management of uterine fbroids (UFs) has led to the discovery of various novel agents in recent years.
    [Show full text]
  • Clinical Study Protocol M12-815 a Phase 3 Study to Evaluate The
    NCT02654054 Elagolix (ABT-620) M12-815 Protocol Amendment 3 1.0 Title Page Clinical Study Protocol M12-815 A Phase 3 Study to Evaluate the Efficacy and Safety of Elagolix in Combination with Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Premenopausal Women Incorporating Amendments 1, 2 and 3 AbbVie Investigational Product: Elagolix (ABT-620) Date: 25 September 2017 Development Phase: 3 Study Design: Phase 3, randomized, double-blind, multicenter, placebo-controlled study evaluating the efficacy, safety and tolerability of elagolix alone and in combination with estradiol/norethindrone acetate for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women 18 to 51 years of age. Investigators: Multicenter Trial: Investigator information is on file at AbbVie Sponsor: AbbVie Sponsor/Emergency Contact: This study will be conducted in compliance with the protocol, Good Clinical Practice and all other applicable regulatory requirements, including the archiving of essential documents. Confidential Information No use or disclosure outside AbbVie is permitted without prior written authorization from AbbVie. 1 Elagolix (ABT-620) M12-815 Protocol Amendment 3 1.1 Protocol Amendment: Summary of Changes Previous Protocol Versions Protocol Date Original 06 November 2015 Amendment 1 01 December 2015 Amendment 2 23 June 2016 The purpose of this Amendment is to: ● Update Section 1.1 Protocol Amendment: Summary of Changes from Appendix Q to Appendix
    [Show full text]
  • Paris Fun Facts Flyer
    ALSO IN ROW ICANN DNS SYMPOSIUM OARC 33 PARIS 6 MAY 2020 7-8 MAY 2020 9-10 MAY 2020 TOP REASONS TO ATTEND Discuss topics concerning contracted parties. Find solutions to issues relevant to your company. Stay ahead of emerging and ongoing operational challenges. Learn and network with other registries and registrars. Get quality face-to-face time with the ICANN sta. VENUE Paris Marriott Rive Gauche Hotel & Conference Center PARIS Trivia Founded in the 3rd Century BC, Paris is more than 2,000 years old. There are over 1,800 monuments and 170 museums in Paris. The Paris Metro is one of the top-five busiest metro systems in the world with more than 1.5 billion passengers per year. The Eiel Tower was built in preparation for the World’s Fair of 1889 where it received two million visitors. CONTACT US: Global Support Center [email protected] EXPLORING PARIS, France Art & Culture Visit the world’s largest art museum: The Louvre Museum is widely considered the greatest art musuem in the world. Quick Facts: Home to Leonardo da Vinci’s Mona Lisa, the Louvre boasts one of the most impressive art collections that dates back to Time Zone: UTC + 2 ancient civilization. Make sure to plan in advance as the Currency: Euro Louvre averages 15,000 visitors per day! Read more: Oicial Language: French https://www.louvre.fr/en Weather: Generally mild in May Visit the Eiel Tower: Originally built for the 1889 World’s (average 68F/20C) Fair, the Eiel Tower was an engineering marvel of its time.
    [Show full text]
  • (Ulipristal Acetate)-Treated Uterine Fibroids
    Journal of Clinical Medicine Article Markers of Inflammation and Vascular Parameters in Selective Progesterone Receptor Modulator (Ulipristal Acetate)-Treated Uterine Fibroids Iwona Szydłowska 1,* , Marta Grabowska 2,* , Jolanta Nawrocka-Rutkowska 1, Andrzej Kram 3, Małgorzata Piasecka 2 and Andrzej Starczewski 1 1 Department of Gynecology, Endocrinology and Gynecological Oncology, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1 Street, 71-252 Szczecin, Poland; [email protected] (J.N.-R.); [email protected] (A.S.) 2 Department of Histology and Developmental Biology, Pomeranian Medical University, Zołnierska˙ 48 Street, 71-210 Szczecin, Poland; [email protected] 3 Department of Pathology, West Pomeranian Oncology Center, Strzałowska 22 Street, 71-730 Szczecin, Poland; [email protected] * Correspondence: [email protected] (I.S.); [email protected] (M.G.); Tel.: +48-91-425-0541 (I.S.) Abstract: The exact mechanism of selective progesterone receptor modulator action in leiomyoma still challenges researchers. The aim of the study was to assess the effects of ulipristal acetate (UPA) on immunoexpression of inflammatory markers and vascularization in fibroids. UPA-treated patients were divided into three groups: (1) good response (≥25% reduction in volume of fibroid), (2) weak response (insignificant volume reduction), (3) and no response to treatment (no decrease or increase in fibroid volume). The percentage of TGFβ, IL6, IL10, CD117, and CD68-positive cells were Citation: Szydłowska, I.; Grabowska, significantly lower in the group with a good response to treatment vs. the control group. Moreover, M.; Nawrocka-Rutkowska, J.; Kram, the percentage of IL10 and CD68-positive cells in the group with a good response to treatment were A.; Piasecka, M.; Starczewski, A.
    [Show full text]
  • Selective Progesterone Receptor Modulators in Gynaecological Therapies
    65 1 Journal of Molecular H O D Critchley and SPRMs in gynaecological 65:1 T15–T33 Endocrinology R Chodankar therapies THEMATIC REVIEW 90 YEARS OF PROGESTERONE Selective progesterone receptor modulators in gynaecological therapies H O D Critchley and R R Chodankar MRC Centre for Reproductive Health, The University of Edinburgh, The Queen’s Medical Research Institute, Edinburgh Bioquarter, Edinburgh, UK Correspondence should be addressed to H O D Critchley: [email protected] This review forms part of a special section on 90 years of progesterone. The guest editors for this section are Dr Simak Ali, Imperial College London, UK, and Dr Bert W O’Malley, Baylor College of Medicine, USA. Abstract Abnormal uterine bleeding (AUB) is a chronic, debilitating and common condition Key Words affecting one in four women of reproductive age. Current treatments (conservative, f abnormal uterine medical and surgical) may be unsuitable, poorly tolerated or may result in loss of fertility. bleeding (AUB) Selective progesterone receptor modulators (SPRMs) influence progesterone-regulated f heavy menstrual bleeding (HMB) pathways, a hormone critical to female reproductive health and disease; therefore, f selective progesterone SPRMs hold great potential in fulfilling an unmet need in managing gynaecological receptor modulators disorders. SPRMs in current clinical use include RU486 (mifepristone), which is licensed (SPRM) for pregnancy interruption, and CDB-2914 (ulipristal acetate), licensed for managing AUB f leiomyoma in women with leiomyomas and in a higher dose as an emergency contraceptive. In this f fibroid article, we explore the clinical journey of SPRMs and the need for further interrogation of this class of drugs with the ultimate goal of improving women’s quality of life.
    [Show full text]
  • Course Description Course Learning Outcomes General Education
    INTRO TO ART THROUGH PARIS MUSEUMS in Fall 2019 (AH1003C) Course Code AH1003C Professor(s) Iveta Slavkova, Marsha Libina Prerequisites None Office Number C-504 Class Schedule R: 09:00-11:55 in SD-6 Office Hours Monday 10h30-12h Credits 4 Email [email protected], [email protected] Semester Fall 2019 Office Tel. Ext. 633 Course Description COURSE DESCRIPTION: This course introduces the History of Western Art through the incomparably rich collections of the museums in Paris. From antiquity to modernity, we will examine a limited number of objects in depth that illuminate particularly well the social, historical, religious or cultural milieus in which they were created. We will study artworks in all media with a variety of subjects, including mythological, religious, and historical themes, as well as portraits, landscapes, and abstraction. Course Learning Outcomes Recognition of major masterpieces in Parisian museums. Establishing historical chronology. Ability to describe and analyze works of art and to identify their style-periods and cultures. Mastery of art-historical terminology. Local and Global Perspectives: Students will enhance their intercultural understanding of languages, cultures, and histories of local societies and the global issues to which these relate (CCI LO1) Aesthetic Inquiry and Creative Expression: Students will engage with artistic or creative objects (e.g., visual art, theatrical works, film) in different media and from a range of cultural traditions (CCI LO2) General Education 1 / 8 GENERAL EDUCATION: The general education program at AUP consists of four requirements: Speaking the World, Modeling the World, Mapping the World, and Comparing Worlds Past and Present. This course can be used to fulfill the Comparing Worlds Past and Present requirement Course Outline OUTLINE: Please note that this course is held almost exclusively in museums and the time for a group visit is limited.
    [Show full text]